Preclinical gene therapy for genetic urinary bladder disease
Preclinical gene therapy for genetic urinary bladder disease
批准号:
MR/T016809/1
负责人:
Adrian Woolf
金额:
$62.12万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In this project we will test cures for a devastating bladder disease. This disease runs in families and makes children and adults unable to fully empty their bladders. Instead, urine builds up in the bladder and becomes infected, causing kidney failure. At present there is no cure for this disease and affected people need to put a catheter into their bladder several times a day to drain urine.Our Manchester research team have identified two faulty genes in people who have this disease. We discovered that these genes control how nerves grow into the bladder. These same nerves then control how our bladders fill up and store urine, and also control how our bladders change shape to let us pass water. We also study mice with the same genetic condition. Like people with the disease, the mice have trouble emptying their bladders. In this project we will use 'gene therapy' to cure these mice that have genetic urinary bladder disease. The therapy is given to mice just after they are born to give the best chance of treating the disease before it has done too much damage.The successful outcome of our project will be a first step towards curing people with severe bladder disease beginning in childhood. This would mean that these people no longer have life-long incontinence of urine.In future, this new type of treatment could be used in other life-threatening inherited genetic diseases that affect the kidney and urinary bladder. Such diseases are important causes of kidney failure in children and young adults and yet they currently have no definitive cures.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Narrowing the chromosome 22q11.2 locus duplicated in bladder exstrophy-epispadias complex.
缩小膀胱外翻-尿道上裂复合体中复制的染色体 22q11.2 位点。
DOI:
10.1016/j.jpurol.2022.04.006
发表时间:
2022
期刊:
Journal of pediatric urology
影响因子:
2
作者:
[Beaman GM]
通讯作者:
Beaman GM
DOI:
10.1093/ndt/gfac207
发表时间:
2022-11-23
期刊:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
影响因子:
--
作者:
[]
通讯作者:
Neurogenic Defects Occur in LRIG2-Associated Urinary Bladder Disease.
LRIG2相关膀胱疾病中发生神经源缺陷。
DOI:
10.1016/j.ekir.2023.04.017
发表时间:
2023-07
期刊:
KIDNEY INTERNATIONAL REPORTS
影响因子:
6
作者:
[Grenier, Celine, Lopes, Filipa M., Cueto-Gonzalez, Anna M., Rovira-Moreno, Eulalia, Gander, Romy, Jarvis, Benjamin W., McCloskey, Karen D., Gurney, Alison M., Beaman, Glenda M., Newman, William G., Woolf, Adrian S., Roberts, Neil A.]
通讯作者:
Roberts, Neil A.
DOI:
10.1038/s41598-023-38110-z
发表时间:
2023-08-14
期刊:
SCIENTIFIC REPORTS
影响因子:
4.6
作者:
[Kabir, Mitra, Stuart, Helen M., Lopes, Filipa M., Fotiou, Elisavet, Keavney, Bernard, Doig, Andrew J., Woolf, Adrian S., Hentges, Kathryn E.]
通讯作者:
Hentges, Kathryn E.
DOI:
10.1016/j.ekir.2020.07.001
发表时间:
2020-10
期刊:
Kidney international reports
影响因子:
6
作者:
[Harkness JR, Beaman GM, Teik KW, Sidhu S, Sayer JA, Cordell HJ, Thomas HB, Wood K, Stuart HM, Woolf AS, Newman WG]
通讯作者:
Newman WG
共 9 条
Molecular bases of congenital bladder disease: the urofacial syndome (UFS)
-
批准号:MR/L002744/1
-
项目类别:Research Grant
-
资助金额:$64.69万
-
财政年份:2013
-
负责人:Adrian Woolf
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
-
批准号:82371801
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:周海波
-
依托单位:
Pik3r2基因突变在家族内侧颞叶癫痫中的作用及发病机制研究
-
批准号:82371454
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:郝勇
-
依托单位:
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
-
批准号:82370906
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:代杰文
-
依托单位:
发展基因编码的荧光探针揭示趋化因子CXCL10的时空动态及其调控机制
-
批准号:32371150
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:井淼
-
依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
-
批准号:82371141
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈颖
-
依托单位:
RET基因634位点不同氨基酸改变对甲状腺C细胞的影响与机制研究
-
批准号:82370790
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶蕾
-
依托单位:
lncGEI诱导湖羊卵巢颗粒细胞E2合成的分子机制
-
批准号:32372856
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李隐侠
-
依托单位:
KMT2A基因突变通过DNMT3靶向调控GBP2导致神经发育障碍的机制研究
-
批准号:82371867
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王剑
-
依托单位:
综合医疗机构引入Gene-Xpert MTB/RIF技术早期发现传染性肺结核和耐药肺结核的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:
-
依托单位:
NFATc3转录调控MMP14介导少突胶质细胞瘤血管新生促肿瘤恶变的机制研究
-
批准号:32100563
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:齐琳
-
依托单位: